130 likes | 163 Views
This study evaluates the impact of an intervention program aimed at improving patient carers' understanding of antimalarial drugs for uncomplicated malaria in children. The research also assesses the rational use of medication for malaria treatment in children through pre-post intervention comparison with a control group, focusing on patient demographics, appropriate prescribing levels, patient/carer understanding of medication usage, dosage, frequency, duration of treatment, and follow-up data. Conclusions suggest significant improvement in patient outcomes and compliance issues with recommendations for improved labeling and information provision.
E N D
IMPACT OF AN INTERVENTION PROGRAM FOR THE TREATMENT OF MALARIA IN CHILDREN IN PAPUA NEW GUINEA V.Bruce Sunderland Isaac Joshua and Phillip Passmore School of Pharmacy Curtin University of Technology Kent Street Bentley Western Australia 6102
INTRODUCTION • Malaria is a significant disease • Few studies have evaluated patient understanding of antimalarial medication • A Study in China has shown improved understanding of antimalarials following blister packaging and provision of written instruction
AIMS • Evaluate the impact of an intervention program on patient carers on the understanding of antimalarial drugs in children for uncomplicated malaria. • Evaluate the level of rational use of medication for uncomplicated malaria in children
METHODS • Pre-post intervention with control group • Prescribing was reported • Patients completed questionnaires on past and present medications and compliance. Advise treatment outcome • Intervention: - provision of labelled directions - completion of treatment - return to clinic to advise treatment outcome • Statistics Pre-post differences using Chi-Squared, Kruskal-Wallis, Fisher’s Exact or Student’s t-tests • Standard Treatment Guidelines
RESULTS Table 1 Patient demographics at the clinic pre-post and control pre-post groups
Table 2: LEVELS OF APPROPRIATE PRESCRIBING IN ACCORDANCE WITH THE PNG PRESCRIBING GUIDELINES P-value from Fisher’s Exact Test
Table 3 PATIENT/CARER UNDERSTANDING OF • USE OF THE MEDICINE
Table 4 PATIENT CARERS RESPONSES TO ASPECTS OF KNOWLEDGE ABOUT MEDICINES P-value from Kruskal-Wallis Test
Table 5 FOLLOW UP DATA COMPARING CONTROL PRE-POST AND CLINIC PRE-POST P-value from Fisher’s Exact Test
CONCLUSIONS • Targeted intervention had no impact on basic understanding of medication administration • Significant understanding of issues related to compliance • Significant improvement in patient outcomes • Improved labelling and information on what procedures to follow if a dose is vomited. • Provision of liquid medicines should be considered.